Bottomline: Can GSK Velu's Neuberg Diagnostics sustain its acquisition-led growth?

Diagnostics service provider Neuberg Diagnostics, which is reportedly preparing for a $350-million initial public offering (IPO) next year, recorded strong growth in its topline and profitability for the financial year ended March 2025, VCCircle has learnt.  The Chennai-based company, backed by Kotak Alternate Assets, recorded around 12% growth in consolidated revenue ......